UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Quality of life research, ISSN 0962-9343, 8/2019, Volume 28, Issue 8, pp. 2247 - 2254
Public Health | Terminal complement inhibition | Myasthenia gravis | Medicine & Public Health | Quality of Life Research | Eculizumab | Fatigue | Complement | Sociology, general | Neuro-QOL Fatigue | Quality of life | Health Care Sciences & Services | Public, Environmental & Occupational Health | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Activities of Daily Living | Placebos - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Fatigue - drug therapy | Humans | Middle Aged | Quality of Life | Female | Male | Receptors, Cholinergic - immunology | Outcome Assessment, Health Care | Myasthenia Gravis - drug therapy | Analysis | Activities of daily living | Index Medicus | Brief Communication
Journal Article
Muscle & nerve, ISSN 0148-639X, 07/2019, Volume 60, Issue 1, pp. 14 - 24
MGC | myasthenia gravis | MG‐ADL | eculizumab | QMG | MG‐QOL15 | MG-ADL | MG-QOL15 | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Meningococcal Infections - epidemiology | Meningococcal Vaccines - therapeutic use | Humans | Middle Aged | Male | Aspergillosis - epidemiology | Activities of Daily Living | Aspergillosis - etiology | Heart Diseases - epidemiology | Meningococcal Infections - etiology | Adult | Female | Heart Diseases - chemically induced | Injection Site Reaction - epidemiology | Muscle Strength | Angioedema - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Injection Site Reaction - etiology | Meningococcal Infections - prevention & control | Treatment Outcome | Disease Progression | Myasthenia Gravis - physiopathology | Complement Inactivating Agents - therapeutic use | Quality of Life | Angioedema - chemically induced | Longitudinal Studies | Myasthenia Gravis - drug therapy | Myasthenia gravis | Effectiveness | Activities of daily living | Antibodies | Neuromuscular junctions | Remission | Myasthenia | Pharmacology | Safety | Muscular strength | Quality of life | Index Medicus | Clinical | Clinical s
Journal Article
Quality of life research, ISSN 0962-9343, 8/2019, Volume 28, Issue 8, pp. 2255 - 2255
Journal Article
Journal of the neurological sciences, ISSN 0022-510X, 12/2019, Volume 407, pp. 116419 - 116419
Journal Article
Annals of clinical and translational neurology, ISSN 2328-9503, 2020, Volume 7, Issue 8, pp. 1327 - 1339
Journal Article
Pediatric rheumatology online journal, 05/2017, Volume 15, Issue S1, pp. 1 - 104
Journal Article
International journal of molecular sciences, ISSN 1661-6596, 09/2014, Volume 15, Issue 9, pp. 15377 - 15395
Biosurfactant | Agroindustrial substrates | Spread oil | Bioemulsifier | Reduction in viscosity | Cunninghamella echinulata | Polymeric molecule | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Viscosity | Water | Soybeans | Temperature | Surface Tension - drug effects | Surface-Active Agents - isolation & purification | Cunninghamella - metabolism | Micelles | Brazil | Emulsifying Agents - isolation & purification | Biodegradation, Environmental | Carbon - metabolism | Fuel Oils | Nitrogen - metabolism | Zea mays | Soil Microbiology | Drug Stability | Industrial Waste | Cunninghamella - chemistry | Salinity | Cunninghamella - isolation & purification | Fungal Proteins - analysis | Emulsifying Agents - chemistry | Hydrophobic and Hydrophilic Interactions | Carbohydrates - analysis | Surface-Active Agents - chemistry | Lipids - analysis | Cunninghamella - growth & development | Hydrogen-Ion Concentration | Surfactants | Soils | Biology | Index Medicus | reduction in viscosity | spread oil | bioemulsifier | biosurfactant | polymeric molecule | agroindustrial substrates
Journal Article
Journal of neurology, ISSN 0340-5354, 2020, Volume 267, Issue 7, pp. 1991 - 2001
Refractory | Neurology | Myasthenia gravis | Clinical Neurology | Minimal symptom expression | Eculizumab | Acetylcholine receptor | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Activities of daily living | Acetylcholine receptors | Neuromuscular junctions | Myasthenia | Patients | Quality of life | Index Medicus | Original Communication
Journal Article